Literature DB >> 8101303

Acute liver failure: redefining the syndromes.

J G O'Grady1, S W Schalm, R Williams.   

Abstract

Existing definitions of clinical syndromes in acute liver failure do not accurately reflect important differences in clinical features and prognosis. Based on a large series of patients with acute liver failure treated at King's College Hospital, London between 1972 and 1985, we propose a new terminology. Hyperacute liver failure is our suggested term for cases in which encephalopathy occurs within 7 days of the onset of jaundice; this group includes the sizeable cohort likely to survive with medical management despite the high incidence of cerebral oedema. We suggest the term acute liver failure for cases with an interval of between 8 and 28 days from jaundice to encephalopathy; they also have a high incidence of cerebral oedema, but have a much poorer prognosis without liver transplantation. The term subacute liver failure is suggested to describe cases with encephalopathy that occurs within 5 to 12 weeks of the onset of jaundice; these patients are characterised by a low incidence of cerebral oedema, but have a poor prognosis. Adoption of this terminology should help in the management of these patients, in addition to standardising the structure and interpretation of controlled trials of therapies.

Entities:  

Mesh:

Year:  1993        PMID: 8101303     DOI: 10.1016/0140-6736(93)91818-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  159 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Fulminant hepatic failure associated with triazolam.

Authors:  Tatsuo Kanda; Osamu Yokosuka; Keiichi Fujiwara; Hiromitsu Saisho; Hidetoshi Shiga; Shigeto Oda; Keiko Okuda; Yasuhiko Sugawara; Masatoshi Makuuchi; Hiroyuki Hirasawa
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

3.  Fulminant Hepatic Failure.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04

4.  Natural history and risk factors in fulminant hepatic failure.

Authors:  U Poddar; B R Thapa; A Prasad; A K Sharma; K Singh
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

5.  [The myth of Prometheus mirrored in intensive medicine].

Authors:  M Thiel
Journal:  Anaesthesist       Date:  2004-06       Impact factor: 1.041

6.  Amyloidosis and subacute liver failure.

Authors:  Moby Joseph; Timothy J S Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

Review 7.  Acute liver failure.

Authors:  J G O'Grady
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

Review 8.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

Review 9.  New technologies - new insights into the pathogenesis of hepatic encephalopathy.

Authors:  Luisa Baker; Bernard Lanz; Fausto Andreola; Javier Ampuero; Anisha Wijeyesekera; Elaine Holmes; Nicolaas Deutz
Journal:  Metab Brain Dis       Date:  2016-09-30       Impact factor: 3.584

Review 10.  Hepatic disorders. Features and appropriate management.

Authors:  M A Aldersley; J G O'Grady
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.